• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Roche

New authorized Roche COVID-19 test can also detect viral loads

June 15, 2022 By Sean Whooley

Roche announced today that it received FDA emergency use authorization (EUA) for its cobas SARS-CoV-2 Duo diagnostic. Authorization covers the cobas SARS-CoV-2 Duo on the fully automated cobas 6800/8800 systems, expanding Roche’s COVID-19 portfolio and representing the first automated, RT-PCR assay for the in vitro qualitative and quantitative detection of SARS-CoV-2 RNA in nasal and […]

Filed Under: Diagnostics, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: FDA, Roche, Roche Diagnostics

Roche says its research-only COVID-19 tests can detect a range of variants, subvariants

March 16, 2022 By Sean Whooley

Roche announced today that its TIB Molbiol subsidiary has made available testing solutions that can identify a number of COVID-19 variants. Basel, Switzerland-based Roche’s testing offerings can identify the SARS-CoV-2 (the virus causing COVID-19) B.1.1.529 variant and differentiate between the omicron subvariants BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and delta, according to a news release. VirSNiP […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, Research & Development Tagged With: coronavirus, COVID-19, Roche, Roche Diagnostics

How medtech and pharma are responding to Russia’s invasion of Ukraine

March 10, 2022 By Danielle Kirsh

Medtech and pharma companies continue to support Ukraine relief efforts following Russia’s invasion. Previously, the World Health Organization announced that it was sending “essential medical supplies” to Ukraine — including its first shipment of 36 metric tons of supplies for trauma care and emergency surgery and other health supplies — to meet the needs of more than […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Dental, Diagnostics, Featured, Hospital Care, Imaging, News Well, Oncology, Orthopedics, Patient Monitoring, Pharmaceutical Tagged With: 3m, Abbott, AdvaMed, Boston Scientific, conformis, Henry Schein, Honeywell, Johnson & Johnson, Medicom, Medtronic, Philips, Roche, Siemens Healthineers, Ukraine, World Health Organization

World Health Organization sending 36 metric tons of medical supplies to Ukraine

March 2, 2022 By Danielle Kirsh

The World Health Organization today said that it is sending more than 36 metric tons of medical supplies to support the humanitarian emergency in Ukraine following Russia’s invasion last week. WHO Director-General Tedros Adhanom Ghebreyesus said the organization is sending “essential medical supplies” to Ukraine — including its first shipment of 36 metric tons of […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Dental, Diagnostics, Distribution, Featured, Hospital Care, Imaging, Implants, Orthopedics, Pharmaceutical Tagged With: conformis, Henry Schein, Medicom, Roche, Siemens Healthineers

Roche launches its connected blood glucose meter in Europe

January 12, 2022 By Sean Whooley

Roche announced today that it launched its Cobas Pulse system in select countries accepting CE mark approval in Europe. Basel, Switzerland-based Roche designed its Cobas Pulse system to combine the form factor of a high-performance blood glucose meter with simple usability and expanded digital capabilities comparable to that of a smartphone. The platform joins Roche’s connected […]

Filed Under: Business/Financial News, Diabetes, Featured, Hospital Care, Patient Monitoring, Regulatory/Compliance Tagged With: CE Mark, Roche

Glytec partners with Roche to enhance insulin dosing decision support software

January 12, 2022 By Sean Whooley

Glytec announced today that it entered into a strategic partnership with Roche Diagnostics USA for a digital health collaboration. Waltham, Massachusetts-based Glytec’s partnership combines its FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions in an effort to address the challenges associated with inpatient blood sugar management at the hospital bedside. […]

Filed Under: Big Data, Business/Financial News, Diabetes, Digital Health, Featured, Health Technology, Hospital Care, Patient Monitoring, Software / IT Tagged With: Glytec, Roche

Freenome raises $290M from Roche

January 11, 2022 By Chris Newmarker

Freenome said today that it has raised $290 million from Roche to advance its cancer early detection platform, which uses a routine blood draw. The South San Francisco, California–based company has raised more than $1.1 billion since its founding in 2014. “With Roche’s investment and expertise, we’ll be able to further accelerate and augment the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, News Well, Oncology Tagged With: Freenome, Roche

Medtech M&A: The industry’s biggest mergers and acquisitions of 2021

November 5, 2021 By Sean Whooley

Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more. Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired. Here are the 10 biggest mergers and acquisitions in medtech in […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Baxter, Boston Scientific, GE Healthcare, Grail, Hillrom, Illumina Inc., Medtronic, PerkinElmer Inc., Philips, Roche, Sanofi, Siemens Healthineers, Thermo Fisher Scientific, Varian Medical Systems, Vectura

FDA approves Genentech’s Susvimo drug-eluting eye implant

October 22, 2021 By Sean Whooley

Genentech announced today that it received FDA approval for its Susvimo injection for treating macular degeneration (AMD). South San Francisco-based Genentech, a member of the Roche Group, designed its Susvimo ranibizumab injection (100 mg/mL) for intravitreal use via ocular implant for treating people with wet, or neovascular, age-related macular degeneration (AMD) who have previously responded to […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Optical/Ophthalmic, Regulatory/Compliance Tagged With: FDA, Genentech, Roche

Europe approves Roche’s Enspryng subcutaneous NMOSD treatment

June 28, 2021 By Sean Whooley

Roche (SWX: RO, ROG) announced today that the European Commission approved its Enspryng subcutaneous NMOSD treatment. Basel, Switzerland-based Roche developed Enspryng (satralizumab) to treat adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD). Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Drug-Device Combinations, Neurological, Regulatory/Compliance Tagged With: European Commission, Roche

Roche wins EUA for intravenous tocilizumab in treating COVID-19

June 25, 2021 By Sean Whooley

Roche announced today that it received FDA emergency use authorization (EUA) for intravenous Actemra/RoActemra in treating COVID-19. Basel, Switzerland-based Roche’s Actemra/RoActemra (tocilizumab) drug received authorization to treat COVID-19 in hospitalized adults and pediatric patients (two years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation or […]

Filed Under: Blog Tagged With: coronavirus, COVID-19, FDA, Roche

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS